G
GenomeDx Biosciences
Genomic information company headquartered in Vancouver, British Columbia, with laboratories in San Diego, California
About GenomeDx Biosciences
GenomeDx, through its Decipher genomic tests, specializes in providing advanced diagnostic solutions for urologic cancers. The company serves healthcare providers and patients by offering genomic tests that deliver precise diagnostic insights, aiding in the effective management and treatment of urologic cancers. Operating in the healthcare and biotechnology market, GenomeDx employs a business model that focuses on the development and commercialization of genomic tests. Revenue is generated through the sale of these tests to medical institutions and healthcare professionals. The company's core product, Decipher, is designed to improve patient outcomes by providing detailed genomic information that informs treatment decisions.
Source: Dealroom company dataNews
Open roles
GenomeDx Biosciences in the Vancouver ecosystem
The GenomeDx Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Calibrium
Robert W. Baird & Co.
Merck & Co.
Series B and later1 investor entered at this stage
- CLCRG LP
Source: Dealroom Talent Intelligence.
See GenomeDx Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

